Usefulness of the patient information leaflet (PIL) and information on medicines from professionals: A patients’ view. A qualitative study
Abstract
Background: The Patient information leaflet (PIL) is an important source of information for every patient. Little is known about whether patients read the PIL and whether it contains useful information. Other sources of drug-related information are professionals (a family practitioner, a pharmacist and a nurse). Informing patients on drugs improves their compliance.
The aim of the study was to identify the usefulness of PIL from the perspective of the patient, to assess professionals as a source of drug-related information and to suggest changes that can improve informing and therefore patients’ compliances.
Methods: Four focus group interviews were conducted across different primary health care centres in the North East of Slovenia. Focus groups were composed of randomly selected patients (in total 20) who were willing to express their views on PILs, on other drug information sources and on possible improvements. A qualitative analysis of the data was based of the transcription of the audiotapes.
Results: Patients read the PILs selectively. They were most interested in side effects, contraindications and the purpose of the prescribed drug. Participants reported that the language in PILs is too scientific. In the case they do not understand PILs or they recognise some of the side effects, a majority of participants decide to contact a family physician first, and less frequently a pharmacist or a nurse. A family physician is considered to be the most trustworthy source of information and patients think that pharmacists could play a more active role in patients’ education.
Conclusion: Current PILs offer enough partial information to patients but need some improvements in terms of better legibility and access to the most crucial information. PIL does not enable a comprehensive information with respect to patient’s health status. Most reliable source of information is considered to be a family practitioner. Pharmacists could play a more active role in the education of patients.
Downloads
References
Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care 2003; 12: 29–34.
Poslovno poročilo za leto 2012. Zavod za zdravstveno zavarovanje Slovenije. Ljubljana, 2013 http://www.zzzs.si/zzzs/info/egradiva- accessed on 30th of March 2013
Švab I, Petek ŠM, Kersnik J, Živcec KG, Car J. A cross sectional study of performance of Slovene general practitioners (English summary). Zdrav Var 2005; 44: 183–192.
Kersnik J, Rekanović K. Poznavanje zdravil iz domače lekarne. Zdrav Var 2003; 42: 66–70.
Golub J, Švab I. Razširjenost neželenih učinkov med recepta prostimi zdravili in zdravili na recept v občini Slovenska Bistrica. Zdrav Var 2007; 46: 63–68.
Klemenc-Ketis Z, Hladnik Z, Kersnik J. Self-medication among Healthcare and Non-healthcare Students at University of Ljubljana, Slovenia. Med Princ Pract 2010; 19: 395–401.
Zafar SN, Syed R, Wagar S, Zubairi AJ, Vagar T, Shaikh M, Yousaf W, Shahid S, Saleem S. Self-medication amongst university students of Karachi: prevalence, knowledge and attitudes. J Pak Med Assoc 2008; 58: 214–217.
Lucas R, Lunet N, Carvalho R, Langa J, Muanantatha M, Nkunda LP, Barros H. Patterns in the use of medicines by university students in Maputo, Mozambique. Cad Saude Publica 2007; 23: 2845–2852.
Raynor TDK. Medication Literacy Is a 2-Way Street. Mayo Clin Proc 2008; 83: 520–522.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331–42.
Directive 2001/83/EC of the European parliament on the community code relating to medicinal products for human use. Official Journal l – 311, 28/11/2004, p. 67–128. http://www.edctp.org/fileadmin/documents/ethics/DIRECTIVE_200183EC_OF_THE_EUROPEAN_PARLIAMENT.pdf. accessed July 12, 2010
Carrigan N, Raynor DK, Knapp P. Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK. Drug Saf 2008; 31: 305–12.
Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets on patient behavior. Isr Med Assoc J 2007; 9: 383–6.
Nathan JP, Zerilli T, Cicero LA, Rosenberg JM. Patients’ use and perception of medication information leaflets. Ann Pharmacother 2007; 41: 777–82.
Labels, patient information leaflets and packaging for medicines. Medicines and Healthcare products Regulatory Agency. London. http://www.mhra.gov.uk/Howweregulate/Medicines/Labelspatientinformationleafletsandpackaging/index.htm. accessed July 12, 2010.
Gupta U, Sharma S, Sheth PD, Jha J, Chaudhury RR. Improving medicine usage through patient information leaflets in India. Trop Doct 2005; 35: 164–6.
Gustafsson J, Kalvemark S, Nilsson G, Nilsson JL. Patient information leaflets’-patients’ comprehension of information about interactions and contraindications. Pharm World Sci 2005; 27: 35–40.
Whatley S, Mamdani M, Upshur Ross EG. A randomised comparison of the effect of three patient information leaflet models on older patients’ treatment intentions. B J Gen Pract 2002; 52: 483–84.
Tarn DM, Heritage J, Paterniti D, Hays , Kravitz , Wenger N. Doctor communication when prescribing new medications. Arch Int Med. 2006; 166: 1855–62.
Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; 2:CD000011. Epub 2008 Apr 16.
Goff SL, Mazor KM, Meterko V, Dodd K, Sabin J. Patients’ beliefs and preferences regarding doctors’ medication recommendations. Gen Intern Med. 2008; 23(3): 236–41.
Kitzinger J. Qualitative Research Introducing focus groups. BMJ 1995; 311: 299–302.
Mays N, Catherine P Qualitative Research: Observational methods in health care settings. BMJ 1995; 311: 182–184.
Pope C, Ziebland S, Mays N. Analysing qualitative data. BMJ 2000; 320: 114–116.
Haw C, Stubbs J. Patient information leaflets for antidepressants: Are patients getting the information they need? Journal of Affective Disorders 2011; 128: 165–170
Schwappach DLB, Mülders V, Simic D, Wilm S and Thürmann PA. Is less more? Patients’ preferences for drug information leaflets. Pharmacoepidem Drug Safe 2011; 20: 987–995.
Hatano T, Kubo SI, Shimo Y, Nishioka K, Hattori N. Unmet needs of patients with Parkinson’s disease: interview survey of patients and caregivers. J Int Med Res 2009; 37: 717–26.
Freund T, Freund M, Mahler C, Schwantes U, Ose D, Joos S, Szecsenyi J. Family practice web sites: new perspectives for patient care and health information? Fam Med 2010; 42: 501–506.
Payer J, Cierny D, Killinger Z, Sulková I, Behuliak M, Celec P. Preferences of patients with post-menopausal osteoporosis treated with bisphosphonates—the VIVA II study. J Int Med Res 2009; 37: 1225–9.
Mendoza DM, Smith SG, Eder M, Hickner J. The Seventh Element of Quality: The Doctor-Patient Relationship. Fam Med 2011; 43: 83–9.
Tarn DM, Flocke SA. New Prescriptions: How Well Do Patients Remember Important Information? Fam Med 2011; 43: 254–259.
Horvat N and Kos M. Slovenian pharmacy performance: a patient-centred approach to patient satisfaction survey content development. Int J Clin Pharm 2011; 33: 985–996.
Salgado MT, Moles R, Benrimoj IS and Fernandez-Llimos F. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study. Int J Clin Pharm 2012; 34: 569–578.
Jarab SA, AlQudah GS, Khdour M, Shamssain M. and Mukattash LT. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm 2012; 34: 53–62.
Zargarzadeh HA, Jacob S, Klotz SR and Khasawneh TF. Clinical pharmacists and basic scientists: do patients and physicians need this collaboration? Int J Clin Pharm 2011; 33: 886–894.
Dolovich L, Pottie K, Kaczorowski J, Farrell B, Austin Z, Rodriguez C, Gaebel K, Sellors C. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008; 83: 913–917.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
